site-selective artificial ribonucleases oligonucleotide conjugates containing multiple imidazole residues in the catalytic domainsite-selective人工核糖核酸酶寡核苷酸轭合物包含多个咪唑残留在催化领域.pdf

site-selective artificial ribonucleases oligonucleotide conjugates containing multiple imidazole residues in the catalytic domainsite-selective人工核糖核酸酶寡核苷酸轭合物包含多个咪唑残留在催化领域.pdf

  1. 1、本文档共18页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
site-selective artificial ribonucleases oligonucleotide conjugates containing multiple imidazole residues in the catalytic domainsite-selective人工核糖核酸酶寡核苷酸轭合物包含多个咪唑残留在催化领域

SAGE-Hindawi Access to Research Journal of Nucleic Acids Volume 2011, Article ID 748632, 17 pages doi:10.4061/2011/748632 Research Article Site-Selective Artificial Ribonucleases: Oligonucleotide Conjugates Containing Multiple Imidazole Residues in the Catalytic Domain Natalia G. Beloglazova,1 Martin M. Fabani,2 Nikolai N. Polushin,3 Vladimir V. Sil’nikov,1 Valentin V. Vlassov,1 Elena V. Bichenkova,2 and Marina A. Zenkova1 1 Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia 2 School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester M13 9PL, UK 3 Fidelity Systems Inc., 7961 Cessna Avenue, Gaithersburg, MD 20879, USA Correspondence should be addressed to Marina A. Zenkova, marzen@niboch.nsc.ru Received 7 April 2011; Accepted 5 July 2011 Academic Editor: Dmitry A. Stetsenko Copyright © 2011 Natalia G. Beloglazova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Design of site-selective artificial ribonucleases (aRNases) is one of the most challenging tasks in RNA targeting. Here, we designed and studied oligonucleotide-based aRNases containing multiple imidazole residues in the catalytic part and systematically varied structure of cleaving constructs. We demonstrated that the ribonuclease activity of the conjugates is strongly affected by the number of imidazole residues in the catalytic part, the length of a linker between the catalytic imidazole groups of the construct and the oligonucleotide, and the type of anchor group, connecting linker structure and the oligonucleotide.

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档